Current Concepts and New Trends in the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction

1. Kaminski KA, Tycinska AM, Stepek T, et al. Natural history and risk factors of long-term mortality in acute coronary syndrome patients with cardiogenic shock. Adv Med Sci. 2014;59:156-60.10.1016/j.advms.2013.12.003Search in Google Scholar

2. Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000;36(Suppl A):1071-6.10.1016/S0735-1097(00)00874-3Search in Google Scholar

3. Jacobs AK, Leopold JA, Bates E, et al. Cardiogenic shock caused by right ventricular infarction. A report from the SHOCK registry. J Am Coll Cardiol. 2003;41:1273-9.10.1016/S0735-1097(03)00120-7Search in Google Scholar

4. Reynolds HR, Hochman JS. Cardiogenic Shock: Current Concepts and Improving Outcomes. Circulation. 2008;117:686-97.10.1161/CIRCULATIONAHA.106.613596Search in Google Scholar

5. Tchantchaleishcili V, Schubmehl H, Swartz MF, Hallinan W, Massey HT. Evolving strategies in the treatment of acutemyocardial infarction-induced cardiogenic schock. Am Cardiothorac Surg. 2014;3:606-11.Search in Google Scholar

6. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-34.10.1056/NEJM199908263410901Search in Google Scholar

7. Hochman JS, Sleeper LA, Godfrey E, et al. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/ CABG-trial design. The SHOCK Trial Study Group. Am Heart J. 1999;137:313-21.10.1053/hj.1999.v137.95352Search in Google Scholar

8. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000;36(Suppl A):1063-70.10.1016/S0735-1097(00)00879-2Search in Google Scholar

9. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190-2.10.1001/jama.285.2.19011176812Search in Google Scholar

10. Webb JG, Sanborn TA, Sleeper LA, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J. 2001;141:964-70.10.1067/mhj.2001.11529411376311Search in Google Scholar

11. Carnendran L, Abboud R, Sleeper LA, et al. Trends in cardiogenic. 10 • The Journal of Critical Care Medicine 2015;1(1) shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart J. 2001;22:472-8.Search in Google Scholar

12. Menon V, Fincke R. Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail. 2003;9:35-9.10.1111/j.1751-7133.2003.tb00020.x12556676Search in Google Scholar

13. Bangalore S, Gupta N, Guo Y, et al. Outcomes with invasive versus conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med. 2014;doi:10.1016/j. am.med.2014.12.009. [Epub ahead of print].Search in Google Scholar

14. Dzavik V, Sleeper LA, Cocke TP, et al. SHOCK Investigators. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828-37.10.1016/S0195-668X(02)00844-8Search in Google Scholar

15. O'Connor CM, Rogers JG. Evidence for overturning the guidelines in cardiogenic shock. N Engl J Med. 2012;367:1349-50.10.1056/NEJMe1209601Search in Google Scholar

16. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010;38:152-60.10.1097/CCM.0b013e3181b78671Search in Google Scholar

17. Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382:1638-42.10.1016/S0140-6736(13)61783-3Search in Google Scholar

18. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-96.10.1056/NEJMoa120841022920912Search in Google Scholar

19. Prodzinsky R, Unverzagt S, Russ M, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012;37:378- 84.10.1097/SHK.0b013e31824a67af22266974Search in Google Scholar

20. Spiro J, Doshi SN. Use of left ventricular support devices during acute coronary syndrome and percutaneous coronary intervention. Curr Cardiol Rep. 2014;16:544.10.1007/s11886-014-0544-x25326728Search in Google Scholar

21. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584-8.10.1016/j.jacc.2008.05.06519007597Search in Google Scholar

22. Moller-Helgestad OK, Poulsen CB, Christiansen EH, Lassen JF, Ravn HB. Support with intra-aortic balloon pump vs Impella 2.5 and blood flow to the heart, brain and kidneys - an experimental porcine model of ischaemic heart failure. Int J Cardiol. 2014;178C:153-8.10.1016/j.ijcard.2014.10.15325464241Search in Google Scholar

23. Jumean M, Pham DT, Kapur NK. Percutaneous bi-atrial extracorporeal membrane oxygenation for acute circulatory support in advanced heart failure. Catheter Cardiovasc Interv. 2014 dec 22. Doi:10.1002/ccd.25791. [Epub ahead of print].10.1002/ccd.2579125529821Search in Google Scholar

24. Loforte A, Pilato E, Martin Suarez S, et al. RotaFlow and CentriMag Extracorporeal Membrane Oxygenation Support Systems as Treatment Strategies for Refractory Cardiogenic Shock. J Card Surg. 2014; doi:10.1111/jocs.12480. [Epub ahead of print].10.1111/jocs.12480Search in Google Scholar

25. Tousek P, Rokyta R, Tesarova J, et al. Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study. Acute Card Care. 2011;13:116-22.10.3109/17482941.2011.567282Search in Google Scholar

26. Rokyta R, Pechman V, Tousek P, Pudil R, Lhotska J, Widimsky P. Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study. Exp Clin Cardiol. 2013;18:81-4.Search in Google Scholar

27. Alexander JH, Reynolds HR, Stebbins AL, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007;297:1657-66.10.1001/jama.297.15.joc70035Search in Google Scholar

28. Schillinger W, Hünlich M, Sossalla S, Hermann HP, Hasenfuss G. Intracoronary pyruvate in cardiogenic shock as an adjunctive therapy to catecholamines and intra-aortic balloon pump shows beneficial effects on haemodynamics. Clin Res Cardiol. 2011;100:433-8.10.1007/s00392-010-0261-4Search in Google Scholar

29. Husebye T, Eritsland J, Müller C, et al. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study. Eur J Heart Fail. 2013;15:565-72.10.1093/eurjhf/hfs215Search in Google Scholar

30. Dixon SR, Whitbourn RJ, Dae MW, et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002;40:1928-34.10.1016/S0735-1097(02)02567-6Search in Google Scholar

31. Menon V, Webb JG, Hillis LD, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000;36(Suppl A):1110-6.Search in Google Scholar

32. Thompson CR, Buller CE, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000;36(Suppl A):1104-9.10.1016/S0735-1097(00)00846-9Search in Google Scholar